Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

NCT00052455 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: lomustine
DRUG: procarbazine hydrochloride
DRUG: temozolomide
DRUG: vincristine sulfate

Sponsor

Institute of Cancer Research, United Kingdom